Search

everythinglearnresearchcommunity

for

Search:↓

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

The study found different balding patterns in men of color.

Women with congenital adrenal hyperplasia showed no prostatic growth.

Doctors should adjust how they treat men with prostate-related urinary problems during and after the COVID-19 pandemic.

Women who lost hair from childhood head radiation are more likely to face mental health issues than men.

New male contraceptive pills show promise in reducing sperm production with mild side effects.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Scientists restored fertility in male mice lacking a key fertility gene by using a modified gene.

The case highlights the complexity of diagnosing high testosterone in older women and the need for thorough testing.

Infertile men are more likely to produce sperm with abnormal chromosome numbers, which can affect pregnancy success and embryo health.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Benign conditions can mimic serious ones in postmenopausal hyperandrogenism, requiring careful diagnosis.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Finasteride for hair loss in young men increases the risk of sexual dysfunction.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Estrogen therapy can help stabilize the hairline in transfeminine individuals.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Testosterone boosts fluid and electrolyte secretion in seminal vesicles, aiding sperm function.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Testosterone therapy improved physical and social health in a male with 49,XXXXY syndrome.

In post-menopausal women, signs of increased male hormones should be checked for possible ovarian cancer.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Zinc and copper levels may affect erectile dysfunction by influencing hormone levels.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.